A new generation of safety short peripheral intravenous catheter (SPIVC) technology designed to keep healthcare workers safe from needlestick injuries and blood exposure is now available from BD Medical, a segment of BD (Becton, Dickinson and Company) and a leading provider of IV catheters.
In addition to proven needlestick protection, BD Insyte Autoguard BC with Blood Control Technology reduces the risk of blood exposure by 95 percent, compared to a nonblood control IV catheter, according to the company. The new blood control technology is a septum inside of the catheter hub designed to prevent blood from leaking out during insertion. During the insertion of SPIVCs, clinicians experience blood leakage. The new BD safety catheter is designed to reduce the risk of mucocutaneous blood exposure. Mucocutaneous exposure refers to blood or body fluid exposure to the mucous membrane of the eyes, nose, mouth, or the skin.
Healthcare professionals are often at risk due to uncooperative patients or patients who may inadvertently move their arm during an SPIVC insertion. As a result of minimizing blood exposure during insertion, the new blood control technology from BD is also expected to minimize contamination of other surfaces such as bed rails, scrubs, shoes, floors or equipment. Pathogens in blood residue on these surfaces can be transferred to healthcare workers, housekeeping staff and visitors who might come in contact with these surfaces. Pathogens can also be taken home, for example, on a nurse's shoes or scrubs.
To learn more about the new BD Insyte Autoguard BC with Blood Control Technology, call (800) 219-7174, ext. 2244. To learn more about BD Making Safety SaferSM, a program that provides nurses and other healthcare professionals with a forum to share information on risks, precautions and interventions, learn from experts and peers, and assist hospitals and other healthcare organizations in addressing ongoing concerns related to blood exposure due to insertion of a SPIVC, visit www.bd.com/bloodcontrol.